Navigation Links
News brief: Benefit of HPV Vaccination, Frequent Screening for Women over 41 is Likely to be Low
Date:2/15/2010

The overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes a new study published online February 15 in the Journal of the National Cancer Institute. The study found that the rate of new infections preventable by vaccination declines with age. Furthermore, new infections among women at any age typically do not progress to cervical intraepithelial neoplasia grade 2 (CIN 2) or CIN 3, the precursors for cervical cancer.

This study was undertaken because researchers wanted to examine whether women's age and the duration of carcinogenic HPV infections influenced subsequent persistence of infection and risk of CIN 2 or worse disease.

Ana Cecilia Rodrguez, M.D., of the Proyecto Epidemiolgico Guanacaste, Fundacin INCIENSA, in San Jos, Costa Rica, and colleagues screened over 9,000 women in Costa Rica aged 18 to 97 years. Those with CIN 2 or worse disease at enrollment were treated and not followed further. Among the remaining participants, those at low risk of CIN 2 or worse were rescreened at 5-7 years (passively followed), whereas higher-risk participants and subsets of low-risk women and initially sexually non-active women were rescreened annually or semiannually (actively followed) for up to 7 years.

Most of the CIN 2 or worse disease diagnosed during the study period was associated with persistent carcinogenic HPV infections that were prevalent, or already present at the time of initial testing.

The vast majority of newly detected carcinogenic HPV infections did not persist and did not lead to CIN 2 or worse disease during the study period, regardless of age. The rate of newly detected carcinogenic HPV infections declined with increasing age and ranged from 35 percent in women aged 18-25 years to 13.5 percent in women aged 42 years and older.

"Understanding the relevance of the concept of duration of infection can improve cervical cancer prevention strategies that integrate prophylactic vaccination with HPV screening," the authors write. "For example, evidence that newly detected infections in older women do not harbor a higher risk of persistence or CIN 2 [or worse disease] than in younger women and that older women acquire fewer new infections indicates that the possible benefit of vaccinating older women is much reduced..."

Study limitations: The most important conclusion that newly-detected HPV infections typically do not progress to CIN2 or worse at any age might not hold beyond the 7 years of follow-up in this study.


'/>"/>
Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. News brief: HPV vaccines may reduce a wide range of genital diseases
2. News brief: Contrast agent with MRI improves detection of lymph nodes metastases
3. News brief: Childhood survivors of CNS cancers and leukemia have lowered educational attainment
4. News brief: SNPs in C-reactive protein are not associated with increased risk of cancer
5. News brief: Knockdown of E2F1 reduces invasive potential of melanoma cells
6. News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
7. News brief: Long-term testicular cancer survivors at high risk for neurological side effects
8. News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response
9. News brief: Arsenic biomethylation required for oxidative DNA damage
10. News brief: Adverse symptom reporting by patients vs. clinicians
11. News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... International ... of nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in ... bodybuilder and nutritional scientist who was determined to create a line of products that ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
(Date:1/20/2017)... ... ... to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of Christmas. ... in Oklahoma City, and a devoted woman of faith. , “Becoming a parent changes ... back of my mind for years, but actually doing it might have been a while ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, Case ... successful education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. ... a federal institution supporting research in Germany ... and patient treatments at the University Clinic Heidelberg as ... The MRIdian Linac program will be headed by ... also heads radiation oncology at the German Cancer Research ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017   Science ... is excited to announce that the first five ... Biology  (RP:CB) have been published in eLife today. ... project represents the first practical evaluation of reproducibility ... in reproducible studies. Unlike other assessments of reproducibility, ...
Breaking Medicine Technology: